ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,021.63
0.57%
Dow Jones
44,860.31
0.28%
US Dollar vs MXN
20.69449
0.13%
Brent Oil
72.34
-0.15%
Bitcoin
93,080.67
1.20%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Pfizer Inc (0Q1N)

  7. Pfizer Inc (0Q1N) Noticias

0Q1N

Pfizer (0Q1N)

Pfizer Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:0Q1N
FechaHoraFuenteTítuloSímboloCompañía
29/10/202409:31Alliance NewsAlliance NewsHundreds of blood cancer patients to benefit from new Pfizer treatmentLSE:0Q1NPfizer Inc
29/10/202406:46Alliance NewsAlliance NewsTOP NEWS: Pfizer swings to third-quarter profit as Paxlovid sales jumpLSE:0Q1NPfizer Inc
03/10/202411:29Alliance NewsAlliance NewsIN BRIEF: Haleon buys GBP230 million in shares from PfizerLSE:0Q1NPfizer Inc
01/10/202404:03Alliance NewsAlliance NewsUPDATE: Pfizer cuts stake in Haleon to 15% with GBP2.7 billion saleLSE:0Q1NPfizer Inc
30/09/202415:59Alliance NewsAlliance NewsTOP NEWS: Pfizer to raise around GBP2.7 billion from Haleon stake saleLSE:0Q1NPfizer Inc
25/09/202407:49Alliance NewsAlliance NewsPfizer, Moderna and BioNTech take patent fight to Court of AppealLSE:0Q1NPfizer Inc
16/09/202405:00Alliance NewsAlliance NewsPfizer hails positive results from two cancer treatment studiesLSE:0Q1NPfizer Inc
30/07/202406:35Alliance NewsAlliance NewsTOP NEWS: Pfizer ups outlook amid first revenue hike since Covid boostLSE:0Q1NPfizer Inc
01/05/202407:42Alliance NewsAlliance NewsTOP NEWS: Pfizer profit declines on lower Covid-related salesLSE:0Q1NPfizer Inc
23/04/202400:27Alliance NewsAlliance NewsModerna, Pfizer/BioNTech set for UK court clash over Covid jab patentsLSE:0Q1NPfizer Inc
09/04/202412:41Alliance NewsAlliance NewsPfizer RSV treatment meets targets in trial of adults under age 60LSE:0Q1NPfizer Inc
21/03/202411:29Alliance NewsAlliance NewsTOP NEWS: Haleon buys back shares worth GBP315 million from PfizerLSE:0Q1NPfizer Inc
19/03/202405:17Alliance NewsAlliance NewsHaleon to buy back shares from Pfizer for GBP315 millionLSE:0Q1NPfizer Inc
18/03/202403:47Alliance NewsAlliance NewsTOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in HaleonLSE:0Q1NPfizer Inc
13/03/202411:28Alliance NewsAlliance NewsIN BRIEF: EU approves Pfizer's Prevenar in children with pneumococcalLSE:0Q1NPfizer Inc
01/03/202412:27Alliance NewsAlliance NewsPfizer targets eight blockbuster drugs by 2030 in new oncology planLSE:0Q1NPfizer Inc
30/01/202406:56Alliance NewsAlliance NewsTOP NEWS: Pfizer backs outlook but 2023 profit falls after Covid boostLSE:0Q1NPfizer Inc
29/01/202402:26Alliance NewsAlliance NewsAstellas and Pfizer's Padcev validated by EMA to treat bladder cancerLSE:0Q1NPfizer Inc
09/01/202407:49Alliance NewsAlliance NewsPfizer's licence application accepted for priority review of TivdakLSE:0Q1NPfizer Inc
08/01/202412:09Alliance NewsAlliance NewsIN BRIEF: Pfizer wins European approval for prostate cancer treatmentLSE:0Q1NPfizer Inc
19/12/202308:13Alliance NewsAlliance NewsTOP NEWS: Pfizer sues Poland and Hungary over Covid debtsLSE:0Q1NPfizer Inc
18/12/202305:04Alliance NewsAlliance NewsAstellas, Merck, Pfizer celebrate US approval for Keytruda plus PadcevLSE:0Q1NPfizer Inc
13/12/202310:11Alliance NewsAlliance NewsTOP NEWS: Pfizer shares slide as 2024 revenue outlook underwhelmsLSE:0Q1NPfizer Inc
12/12/202306:35Alliance NewsAlliance NewsPfizer's USD43 billion Seagen buy given regulatory nodLSE:0Q1NPfizer Inc
11/12/202303:08Alliance NewsAlliance NewsPfizer's Elrexfio wins EU approval for form of multiple myelomaLSE:0Q1NPfizer Inc
01/12/202310:54Alliance NewsAlliance NewsTOP NEWS: Pfizer rethinks weight loss pill after high side effect rateLSE:0Q1NPfizer Inc
14/11/202323:55Alliance NewsAlliance NewsPfizer to axe 500 jobs at Kent site amid cost-cutting programmeLSE:0Q1NPfizer Inc
31/10/202306:45Alliance NewsAlliance NewsTOP NEWS: Pfizer outlook downbeat as swings to loss in third quarterLSE:0Q1NPfizer Inc
20/10/202315:25Alliance NewsAlliance NewsUS FDA approves Pfizer's Penbraya for meningococcal diseaseLSE:0Q1NPfizer Inc
19/10/202310:37Alliance NewsAlliance NewsEU clears Pfizer's USD43 billion takeover of biotech firm SeagenLSE:0Q1NPfizer Inc
 Showing the most relevant articles for your search:LSE:0Q1N

Su Consulta Reciente

BIT
IVG
Iveco Group NV
COIN
GTATUSD
Network GURU
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados

BLACK FRIDAY

ADVFN

Celebrando 25 años Est 1999-2024

Ahorra hasta 60%* en Forex

1 año 40%, 2 años 40% y *3 años 60%

*Durante 3 años $1.035.00 solo $414.00